C
34.50
-0.87 (-2.46%)
| Previous Close | 35.37 |
| Open | 35.28 |
| Volume | 8,889,490 |
| Avg. Volume (3M) | 12,792,628 |
| Market Cap | 16,957,371,392 |
| Price / Earnings (Forward) | 10.37 |
| Price / Sales | 0.100 |
| Price / Book | 0.660 |
| 52 Weeks Range | |
| Earnings Date | 29 Oct 2025 |
| Profit Margin | 2.25% |
| Operating Margin (TTM) | 4.49% |
| Diluted EPS (TTM) | 6.78 |
| Quarterly Revenue Growth (YOY) | 16.60% |
| Quarterly Earnings Growth (YOY) | 12.70% |
| Total Debt/Equity (MRQ) | 65.38% |
| Current Ratio (MRQ) | 1.11 |
| Operating Cash Flow (TTM) | 2.12 B |
| Levered Free Cash Flow (TTM) | 2.51 B |
| Return on Assets (TTM) | 3.86% |
| Return on Equity (TTM) | 12.53% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Bullish | Mixed |
| Healthcare Plans (Global) | Bullish | Mixed | |
| Stock | Centene Corporation | Bullish | Bearish |
AIStockmoo Score
0.8
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | -2.5 |
| Average | 0.75 |
|
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Mid Value |
| % Held by Insiders | 0.46% |
| % Held by Institutions | 99.81% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Politan Capital Management Lp | 30 Jun 2025 | 8,043,255 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 45.00 (Truist Securities, 30.44%) | Buy |
| Median | 40.00 (15.94%) | |
| Low | 34.00 (TD Cowen, -1.45%) | Hold |
| Average | 39.73 (15.16%) | |
| Total | 2 Buy, 8 Hold, 1 Sell | |
| Avg. Price @ Call | 35.13 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 04 Nov 2025 | 44.00 (27.54%) | Hold | 34.50 |
| 12 Sep 2025 | 35.00 (1.45%) | Hold | 33.26 | |
| JP Morgan | 04 Nov 2025 | 38.00 (10.14%) | Hold | 34.50 |
| Goldman Sachs | 31 Oct 2025 | 38.00 (10.14%) | Sell | 35.37 |
| 14 Oct 2025 | 33.00 (-4.35%) | Sell | 36.44 | |
| TD Cowen | 31 Oct 2025 | 34.00 (-1.45%) | Hold | 35.37 |
| Cantor Fitzgerald | 30 Oct 2025 | 41.00 (18.84%) | Hold | 35.02 |
| 26 Aug 2025 | 38.00 (10.14%) | Hold | 28.66 | |
| Truist Securities | 30 Oct 2025 | 45.00 (30.43%) | Buy | 35.02 |
| 12 Sep 2025 | 39.00 (13.04%) | Buy | 33.26 | |
| UBS | 30 Oct 2025 | 42.00 (21.74%) | Hold | 35.02 |
| Morgan Stanley | 14 Oct 2025 | 38.00 (10.14%) | Hold | 36.44 |
| Mizuho | 09 Oct 2025 | 40.00 (15.94%) | Hold | 37.83 |
| Wells Fargo | 07 Oct 2025 | 41.00 (18.84%) | Hold | 38.42 |
| Bernstein | 05 Sep 2025 | 36.00 (4.35%) | Buy | 28.98 |
| Show more | ||||
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |